Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immucell (ICCC) Receivables (2016 - 2025)

Historic Receivables for Immucell (ICCC) over the last 16 years, with Q3 2025 value amounting to $2.6 million.

  • Immucell's Receivables rose 1144.05% to $2.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.6 million, marking a year-over-year increase of 1144.05%. This contributed to the annual value of $3.8 million for FY2024, which is 7130.29% up from last year.
  • Immucell's Receivables amounted to $2.6 million in Q3 2025, which was up 1144.05% from $2.4 million recorded in Q2 2025.
  • In the past 5 years, Immucell's Receivables registered a high of $3.8 million during Q4 2024, and its lowest value of $1.4 million during Q2 2022.
  • Its 5-year average for Receivables is $2.3 million, with a median of $2.3 million in 2024.
  • Its Receivables has fluctuated over the past 5 years, first skyrocketed by 10926.3% in 2021, then plummeted by 3381.23% in 2022.
  • Over the past 5 years, Immucell's Receivables (Quarter) stood at $2.7 million in 2021, then crashed by 33.81% to $1.8 million in 2022, then rose by 23.56% to $2.2 million in 2023, then surged by 71.3% to $3.8 million in 2024, then crashed by 31.55% to $2.6 million in 2025.
  • Its last three reported values are $2.6 million in Q3 2025, $2.4 million for Q2 2025, and $3.4 million during Q1 2025.